PSA free
Selected indexed studies
- [Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)]. (Ann Biol Clin (Paris), 2023) [PMID:36757372]
- Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial. (J Urol, 2023) [PMID:37384841]
- [Free PSA: its routine use is premature in the screening of prostatic cancer]. (Prog Urol, 2000) [PMID:11064911]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem? (2009) pubmed
- Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review. (1996) pubmed
- [Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)]. (2023) pubmed
- Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial. (2023) pubmed
- [Free PSA: its routine use is premature in the screening of prostatic cancer]. (2000) pubmed
- The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer. (1998) pubmed
- Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin. (1993) pubmed
- Prostate-specific antigen. (1999) pubmed
- Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients. (2025) pubmed
- PSA detection using label free graphene FET with coplanar electrodes based microfluidic point of care diagnostic device. (2021) pubmed